Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

GlaxoSmithKline studies GSK-3117391 for rheumatoid arthritis in phase II trial

Jan. 27, 2017

Mitsubishi Tanabe Pharma discovers MMP-9 production inhibitors

Jan. 25, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

FDA, EMA accept Boehringer Ingelheim's BI-695501 for review

Jan. 19, 2017

Orion presents novel bromodomain-containing protein 4 inhibitors

Jan. 18, 2017

EC grants new orphan drug designation to Corbus' JBT-101

Jan. 18, 2017

Dendright extends collaboration with Janssen and adds Arthritis Queensland as a partner

Jan. 17, 2017

FDA extends NDA review period for baricitinib

Jan. 16, 2017

NeuroVive, Karolinska Institutet enter collaboration for cyclophilin inhibitor

Jan. 13, 2017

Human amniotic mesenchymal stem cell transplantation counteracts bone fragility

Jan. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...